# Study to Compare the Effects of Z7200 And Symbicort® Turbohaler on Respiratory Imaging Parameters in Asthmatic Patients

> **NCT02227394** · PHASE2 · COMPLETED · sponsor: **Zambon SpA** · enrollment: 20 (actual)

## Conditions studied

- Asthma
- Asthma Chronic
- Asthma Bronchial
- Asthmatic

## Interventions

- **DRUG:** Z7200
- **DRUG:** Symbicort® Turbohaler®

## Key facts

- **NCT ID:** NCT02227394
- **Lead sponsor:** Zambon SpA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-08
- **Primary completion:** 2014-11
- **Final completion:** 2014-11
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2022-01-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02227394

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02227394, "Study to Compare the Effects of Z7200 And Symbicort® Turbohaler on Respiratory Imaging Parameters in Asthmatic Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02227394. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*